Proteomic studies of early-stage and advanced ovarian cancer patients

Gynecologic Oncology

Volumn 111, Issue 1, 2008, Pages 111-119

  Wang, Jing ^a   Zhang, Xiaowei ^a   Ge, Xiaohui ^a   Guo, Hongyan ^a   Xiong, Guangwu ^a   Zhu, Yan ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis; Mass spectrometry; Ovarian cancer; Proteomic pattern

Indexed keywords

PLASMA PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SUPPORT VECTOR MACHINE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

BLOOD PROTEINS; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 52049093431     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.031     Document Type: Article

References (22)

1. O'Malley C.D., Cress R.D., Campleman S.L., and Leiserowitz G.S. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study. Gynecol. Oncol. 91 (2003) 608-615
2. Jemal A., Thomas A., Murray T., and Thun M. Cancer statistics, 2002. CA Cancer J. Clin. 52 (2002) 23-47
3. Boyce E.A., and Kohn E.C. Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets. Int. J. Gynecol. Cancer 15 Suppl 3 (2005) 266-273
4. Fung E.T., Wright G.L., and Dalmasso E.A. Proteomic strategies for biomarker identification: progress and challenges. Curr. Opin. Mol. Ther. 2 (2000) 643-650
5. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
6. Conrads T.P., Fusaro V.A., Ross S., Johann D., Rajapakse V., Hitt B.A., et al. High-resolution serum proteomic features for ovarian cancer detection. Endocr. Relat. Cancer 11 (2004) 163-178
7. Kozak K.R., Amneus M.W., Pusey S.M., Su F., Luong M.N., Luong S.A., et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc. Natl. Acad. Sci. 100 (2003) 12343-12348
8. Rai A.J., Zhang Z., Rosenzweig J., Shih I., Pham T., Fung E.T., et al. Proteomic approaches to tumor marker discovery. Arch. Pathol. Lab. Med. 126 (2002) 1518-1526
9. Zhang H., Kong B., Qu X., Jia L., Deng B., and Yang Q. Biomarker discovery for ovarian cancer using SELDI-TOF-MS. Gynecol. Oncol. 102 (2006) 61-66
10. Lee Y., and Lee C.K. Classification of multiple cancer types by multicategory support vector machines using gene expression data. Bioinformatics 19 (2003) 1132-1139
11. Gadducci A., Cosio S., Carpi A., Nicolini A., and Genazzani A.R. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed. Pharmacother. 58 (2004) 24-38
12. Jacobs I.J., Skates S.J., MacDonald N., Menon U., Rosenthal A.N., Davies A.P., et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 353 (1999) 1207-1210
13. Wu W., Hu W., and Kavanagh J.J. Proteomics in cancer research. Int. J. Gynecol. Cancer 12 (2002) 409-423
14. Zhang Z., Bast Jr. R.C., Yu Y., Li J., Sokoll L.J., Rai A.J., et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 64 (2004) 5882-5890
15. Kozak K.R., Su F., Whitelegge J.P., Faull K., Reddy S., and Farias-Eisner R. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 5 (2005) 4589-4596
16. Fung E.T., Yip T.T., Lomas L., Wang Z., Yip C., Meng X.Y., et al. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int. J. Cancer 115 (2005) 783-789
17. Kehr J., Hu X.J., Yoshitake T., and Scheller D. Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection. J. Chromatogr., B Analyt. Technol. Biomed. Life. Sci. 845 (2007) 109-113
18. Rai A.J., Gelfand C.A., Haywood B.C., Warunek D.J., Yi J., Schuchard M.D., et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5 (2005) 3262-3277
19. Dijkstra M., Vonk R.J., and Jansen R.C. SELDI-TOF mass spectra: a view on sources of variation. J. Chromatogr. B, Analyt. Technol. Biomed. Life. Sci. 847 (2007) 12-23
20. Lin Y.W., Lin C.Y., Lai H.C., Chiou J.Y., Chang C.C., Yu M.H., et al. Plasma proteomic pattern as biomarkers for ovarian cancer. Int. J. Gynecol. Cancer 16 Suppl 1 (2006) 139-146
21. Diamandis E.P. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell Proteomics. 3 (2004) 367-378
22. Engwegen J.Y., Gast M.C., Schellens J.H., and Beijnen J.H. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci. 27 (2006) 251-259